ScholarIQanswers from OpenAlex

Three-Year Outcomes of Surgical Versus Endovascular Revascularization for Critical Limb Ischemia

PaperCitations, authors & open-access status

Three-Year Outcomes of Surgical Versus Endovascular Revascularization for Critical Limb Ischemia is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Three-Year Outcomes of Surgical Versus Endovascular Revascularization for Critical Limb Ischemia have?

ScholarIQcitation count

Three-Year Outcomes of Surgical Versus Endovascular Revascularization for Critical Limb Ischemia has 180 citations in the OpenAlex counts ScholarIQ stores.

When was Three-Year Outcomes of Surgical Versus Endovascular Revascularization for Critical Limb Ischemia published?

ScholarIQyear

Three-Year Outcomes of Surgical Versus Endovascular Revascularization for Critical Limb Ischemia has 2017 year in the ScholarIQ index.

What is the open-access status of Three-Year Outcomes of Surgical Versus Endovascular Revascularization for Critical Limb Ischemia?

ScholarIQoa status

Three-Year Outcomes of Surgical Versus Endovascular Revascularization for Critical Limb Ischemia has hybrid oa status in the ScholarIQ index.

What is the DOI of Three-Year Outcomes of Surgical Versus Endovascular Revascularization for Critical Limb Ischemia?

ScholarIQdoi

The DOI for Three-Year Outcomes of Surgical Versus Endovascular Revascularization for Critical Limb Ischemia is on the source record.

What is the PMID of Three-Year Outcomes of Surgical Versus Endovascular Revascularization for Critical Limb Ischemia?

ScholarIQpmid

The PMID for Three-Year Outcomes of Surgical Versus Endovascular Revascularization for Critical Limb Ischemia is on the source record.

What is the OpenAlex record for Three-Year Outcomes of Surgical Versus Endovascular Revascularization for Critical Limb Ischemia?

ScholarIQopenalex

The OpenAlex for Three-Year Outcomes of Surgical Versus Endovascular Revascularization for Critical Limb Ischemia is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial